Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$53.78 2.03 (3.92%) as of 4:30 Thu 6/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 122,563,000
Market Cap: 6.59(B)
Last Volume: 8,264,325 Avg Vol: 8,242,049
52 Week Range: $26.88 - $108.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 138,093 288,980 461,958 926,280
Total Sell Value $8,135,395 $19,867,810 $25,677,895 $46,442,456
Total People Sold 7 8 8 12
Total Sell Transactions 11 21 41 87
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1115
  Page 43 of 45  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dow Stephen M Director   –       •       •   2006-02-15 4 B $7.20 $8,640 I/I 1,200 119,200 2.17     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-02-15 4 AS $7.18 $35,920 D/D (5,000) 20,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-02-15 4 OE $1.00 $5,000 D/D 5,000 24,300     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-02-15 4 AS $7.14 $17,850 D/D (2,500) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-02-15 4 OE $0.58 $1,450 D/D 2,500 67,500     -
   Dow Stephen M Director   –       •       •   2006-02-14 4 B $7.20 $138,126 I/I 19,162 118,000 2.25     -
   Dow Stephen M Director   –       •       •   2006-02-13 4 B $7.20 $100,111 I/I 13,838 98,838 2.25     -
   Sabry James H President and CEO   •       •      –    2006-02-08 4 AS $7.20 $51,516 D/D (7,000) 0     -
   Sabry James H President and CEO   •       •      –    2006-02-08 4 OE $0.58 $4,060 D/D 7,000 3,014     -
   Spudich James A officerTitle   –       •      –    2006-02-03 4 AS $7.71 $16,967 D/D (2,200) 237,800     -
   Dow Stephen M Director   –       •      –    2005-11-15 4 B $8.60 $141,991 I/I 16,500 85,000 2.1     -
   Dow Stephen M Director   –       •      –    2005-11-14 4 B $8.34 $71,195 I/I 8,500 68,500 2.1     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-14 4 S $8.30 $48,196 D/D (5,800) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-14 4 OE $1.20 $6,960 D/D 5,800 68,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-14 4 S $8.34 $14,199 D/D (1,700) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-14 4 OE $1.20 $2,040 D/D 1,700 65,800     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-11 4 OE $1.20 $21,000 D/D 17,500 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-11 4 S $8.23 $146,018 D/D (17,500) 64,700     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2005-11-10 4 OE $0.58 $11,600 D/D 20,000 20,000     -
   Sabry James H President and CEO   •       •      –    2005-11-08 4 S $8.50 $17,000 I/I (2,000) 210,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-08 4 S $8.47 $42,350 D/D (5,000) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-08 4 OE $1.20 $6,000 D/D 5,000 70,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-07 4 S $8.65 $43,524 D/D (5,000) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-11-07 4 OE $1.20 $6,000 D/D 5,000 65,100     -
   Sabry James H President and CEO   •       •      –    2005-11-07 4 S $8.70 $52,200 I/I (6,000) 212,000     -
  1115 Records found
  Previous  40  41  42  43  44  45   
  Page 43 of 45
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us